Protocols | ||
---|---|---|
1 protocol(s) meet the specified criteria | ||
Drug: VECTIBIX | ||
Protocol No. | Title | Status |
LCCC1632 | Phase II Trial of Panitumumab, Nivolumab, and Ipilimumab for KRAS/NRAS/BRAF Wild-type MSS Refractory Metastatic Colorectal Adenocarcinoma | Open |
Protocols | ||
---|---|---|
1 protocol(s) meet the specified criteria | ||
Drug: VECTIBIX | ||
Protocol No. | Title | Status |
LCCC1632 | Phase II Trial of Panitumumab, Nivolumab, and Ipilimumab for KRAS/NRAS/BRAF Wild-type MSS Refractory Metastatic Colorectal Adenocarcinoma | Open |